Scleroderma, Limited
Information
- Disease name
- Scleroderma, Limited
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01347008 | Completed | Phase 3 | Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis | April 2011 | January 2013 |
| NCT06425653 | Completed | N/A | Exercise With Scleroderma Functional Outcomes | February 5, 2021 | December 5, 2021 |
| NCT02682511 | Recruiting | Phase 2 | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension | January 2017 | December 2025 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D045745